Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 4/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.41 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.41 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.41 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.41 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 4/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16866695 | 1.00 | IDO1 (0.44) | IDO1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL24140334 | 0.88 | IDO1 (0.47) | IDO1CYP2D6 | |
| SCHEMBL14313350 | 0.81 | TSHR (0.51) | CYP2D6GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL15372611 | 0.81 | RET (0.37) | IDO1SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL9315540 | 0.79 | PLAU (0.47) | IDO1KDM1A | |
| SCHEMBL12089133 | 0.79 | IDO1 (0.33) | IDO1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL2910443 | 0.79 | IDO1 (0.43) | IDO1 | |
| SCHEMBL21300294 | 0.78 | IDO1 (0.66) | IDO1 | |
| SCHEMBL14209228 | 0.78 | IDO1 (0.66) | IDO1 | |
| SCHEMBL447420 | 0.78 | IDO1 (0.66) | IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10818860-B2 | Quantum dot light emitting devices | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2020-10-27 | — | — | US | disclosed |
| US-20190334106-A1 | QUANTUM DOT LIGHT EMITTING DEVICES | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2019-10-31 | — | — | US | disclosed |
| US-20180226584-A1 | POLYMERIC CHARGE TRANSFER LAYER AND ORGANIC ELECTRONIC DEVICE CONTAINING THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-08-09 | — | — | US | disclosed |
| US-9793485-B2 | Benzocyclobutenes derived compositions, and electronic devices containing the same | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-10-17 | — | — | US | disclosed |
| US-20170229656-A1 | BENZOCYCLOBUTENES DERIVED COMPOSITIONS, AND ELECTRONIC DEVICES CONTAINING THE SAME | DOW GLOBAL TECHNOLOGIES LLC | 2017-08-10 | — | — | US | disclosed |
| US-20170170398-A1 | OXYGEN SUBSTITUTED BENZOCLOBUTENES DERIVED COMPOSITIONS FOR ELECTRONIC DEVICES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-06-15 | — | — | US | disclosed |
| US-20170170400-A1 | COMPOSITIONS COMPRISING OXYGEN SUBSTITUTED BENZOCYCLOBUTENES AND DIENOPHILES, AND ELECTRONIC DEVICES CONTAINING THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-06-15 | — | — | US | disclosed |
| US-20170170398-A1 | OXYGEN SUBSTITUTED BENZOCLOBUTENES DERIVED COMPOSITIONS FOR ELECTRONIC DEVICES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180226584-A1 | POLYMERIC CHARGE TRANSFER LAYER AND ORGANIC ELECTRONIC DEVICE CONTAINING THE SAME | CLTB, CYBA, L1CAM | IDO1 2854/4885SLC6A2 1018/4885SLC6A4 1604/4885 |
| US-20170229656-A1 | BENZOCYCLOBUTENES DERIVED COMPOSITIONS, AND ELECTRONIC DEVICES CONTAINING THE SAME | ABCB4, ABCB7, OCIAD2 | IDO1 3055/4885SLC6A2 1304/4885SLC6A4 1639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.